36,360.000
0.001 BRL
1.25 B BRL
9.43 B BRL
About Neurocrine Biosciences, Inc.
Sector
CEO
Kyle W. Gano
Headquarters
San Diego
Website
Founded
1992
ISIN
BRN1BIBDR009
FIGI
BBG00XV3YMP3
Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceuticals for the treatment of neurological, neuroendocrine, and neuropsychiatric disorders. The company was founded by Kevin C. Gorman and Wylie W. Vale in January 1992 and is headquartered in San Diego, CA.
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where N1BI34 is featured.